Virtual Medicinal Product (VMP) - Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler | Start Date 12-06-2014 | End Date |
Abbreviated Name | Abbreviated Name Umeclidinium brom 65microg/Vilanterol 22microg/dose dry pdr | Start Date 02-03-2016 | |
Previous Abbreviated Name | Umeclidinium brom 65microg/Vilanterol 22microg/dose | Previous Start Date 12-06-2014 | Previous End Date 01-03-2016 |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- dose
- Unit Dose UOM
- dose
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Inhalation
- Form
- Inhalation powder
- Ontology Form/Route
- powderinhalation.inhalation
- Name Basis
- Other
Codes
- ATC Code
- R03AL03
BNF | Start Date | End Date |
---|---|---|
Current BNF 03010400 | Start Date 04-04-2022 | End Date |
Previous BNF 03010400 | Start Date 29-08-2014 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
24645511000001105 | 12-06-2014 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Umeclidinium bromide | Based on Ingredient Substance | 65 microgram | 1 dose | |
Vilanterol trifenatate | Based on Base Substance | Vilanterol | 22 microgram | 1 dose |
Name
Umeclidinium bromide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
65.0
Strength and UOM (Dmr)
1.0
Name
Vilanterol trifenatate
Basis of strength description
Based on Base Substance
BOSS
Vilanterol
Strength and UOM (Nmr)
22.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMUmeclidinium bromide + Vilanterol
-
VMP(Current) Umeclidinium bromide 65micrograms/do...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
30 dose | 3250 | Part VIIIA Category C |